Thus, the aim of our study was to investigate the potential role of SNPs in STAT4, PTPN2, PSORS1C1, and TRAF3IP2 as predictors of remission and LDA in a cohort of RA patients treated with first line TNF-i. This evidence concerns the gene STAT4 and rheumatoid arthritis.